NCT01607502 Database for Clinical and Anamnestic Data in Pulmonary Hypertension
| NCT ID | NCT01607502 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2010-07 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2010-07 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization. There are different forms of PH defined in the classification of Dana Point 2008. PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like the echocardiography, stress echocardiography and cardio pulmonary exercise testing. In the diagnosis process and in the follow up of PH patients biomarkers like NTproBNP are helpful. There are no specific biomarkers for the disease which can make the diagnosis process easier and predict prognosis. The systematic data collection in a data base provides better information about patients in daily routine and clinical studies as well as in the design of new studies.
Eligibility Criteria
Inclusion Criteria: * patients with pulmonary hypertension * patients at risk for getting pulmonary hypertension * patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent. Exclusion Criteria: * patients without written informed consent
Contact & Investigator
Horst Olschewski, MD
PRINCIPAL INVESTIGATOR
Medical University of Graz
Frequently Asked Questions
Who can join the NCT01607502 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01607502 currently recruiting?
Yes, NCT01607502 is actively recruiting participants. Contact the research team at horst.olschewski@medunigraz.at for enrollment information.
Where is the NCT01607502 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT01607502 clinical trial?
NCT01607502 is sponsored by Medical University of Graz. The principal investigator is Horst Olschewski, MD at Medical University of Graz. The trial plans to enroll 900 participants.